MediciNova to Buy Avigen for $37 Million
Pharmaceutical company MediciNova announced that it will buy Avigen (AVGN) for $1.24 per share, approximately $37 million.
Pharmaceutical company MediciNova announced that it will buy Avigen (AVGN) for $1.24 per share, approximately $37 million.
CombinatoRx has signed an all-stock merger agreement with Neuromed.
Copyright © 2024 | WordPress Theme by MH Themes